| Literature DB >> 31820807 |
Patrick Bach1, Ulrich Frischknecht1, Svenja Klinkowski1, Melanie Bungert2, Damian Karl1, Christian Vollmert1, Sabine Vollstädt-Klein1, Stefanie Lis2, Falk Kiefer1, Derik Hermann1.
Abstract
Opioid-dependent patients are highly sensitized to negative social feedback, and increased social rejection sensitivity was linked to adverse treatment outcome, but its neurobiological underpinnings have not been understood yet. The present study investigated gray matter (GM) volume differences between 19 opioid maintenance treatment (OMT) patients and 20 healthy controls using magnetic resonance imaging and voxel-based morphometry. Associations of GM volumes with subjective feelings of exclusion and inclusion during a social ostracism (Cyberball) paradigm, with rejection sensitivity, social interaction anxiety and social phobia were explored. OMT patients displayed smaller GM volume in the bilateral insula and inferior frontal gyri. Psychometric and task data showed that patients reported significantly higher rejection sensitivity, social anxiety and social phobia scores and felt more excluded and less included during the social ostracism paradigm. Smaller GM volume in the insula was associated with higher subjective exclusion, lower subjective inclusion and higher rejection sensitivity, social anxiety and social phobia scores. Findings indicate that structural deficits in emotion- and anxiety-processing brain regions in OMT patients are associated with increased social rejection sensitivity. As social rejection is a potential trigger for relapse, patients might benefit from therapeutic strategies that promote social integration.Entities:
Keywords: gray matter volume; insula; opioid addiction; social exclusion; social rejection sensitivity; voxel-based morphometry
Mesh:
Substances:
Year: 2019 PMID: 31820807 PMCID: PMC7057285 DOI: 10.1093/scan/nsz094
Source DB: PubMed Journal: Soc Cogn Affect Neurosci ISSN: 1749-5016 Impact factor: 3.436
Clinical characteristics of study participants
| Variable | Opioid-dependent patients ( | Healthy controls ( | Statistics |
| ||
|---|---|---|---|---|---|---|
| N | N | |||||
| Sex (male/female) | 18:1 | 18:2 | Chi2(1) = 0.171 | 0.581 | ||
| Education (no post-secondary education/apprenticeship only/attended college or higher) | 13/6/0 | 2/9/9 | Chi2(2) = 17.653 | 0.001 | ||
| Medication (methadone/buprenorphine) | 15:4 | — | — | — | ||
| Substance use other than nicotine and methadone (yes/no) | 9:10 | — | — | — | ||
| Drugs used other than methadone (absolute numbers) | BZD = 4, OPT = 7, ALC = 5, THC = 2, COC = 2 | — | — | — | ||
| Variable | Mean | s.d. | Mean | s.d. | ||
| Age (years) | 37.42 | 8.23 | 38.35 | 8.28 |
| 0.727 |
| Duration of heroin abuse (years) | 14.4 | 7.10 | — | — | — | |
| Methadone equivalence dose (mg) | 63.35 | 36.26 | — | — | — | |
| SPS (sum score) | 14.11 | 19.76 | 4.00 | 3.67 |
| 0.016 |
| RSQ (sum score) | 9.75 | 5.96 | 5.08 | 3.53 |
| 0.003 |
| SIAS (sum score) | 22.00 | 17.76 | 13.45 | 7.22 |
| 0.027 |
| BSI (global severity score) | 35.47 | 39.34 | 4.85 | 5.21 |
| 0.001 |
| BSI—subscale interpersonal sensitivity (score) | 2.74 | 3.72 | 0.60 | 1.10 |
| 0.019 |
| BSI—subscale anxiety (score) | 3.53 | 4.50 | 0.80 | 1.01 |
| 0.012 |
| BSI—subscale phobic anxiety (score) | 2.63 | 4.51 | 0.15 | 0.49 |
| 0.019 |
BZD = benzodiazepine, OPT = opiates other than methadone/buprenorphine, ALC = alcohol, THC = tetrahydrocannabinol, COC = cocaine. Methadone equivalence dose was calculated with 100 mg methadone = 16 mg buprenorphine (Strain ).
a n = 8 patients consumed more than one drug other than methadone and nicotine concurrently.
*Significant group differences at P < 0.05.
#Significant group differences at P < 0.05 after controlling for partnership status.
†Significant group differences at P < 0.05 after controlling for education level.
°Significant group differences at P < 0.05 after controlling for partnership status and education level concurrently.
Significant whole-brain GM volume differences between opioid maintenance patients (n = 19) and controls (n = 20) (N = 39, combined voxel-wise (P < 0.001) and cluster-extent (cluster size >103 voxel) threshold, corresponding to pFWE < 0.05 whole brain corrected)
| Side | Lobe | Brain areas | Cluster size (voxel) | MNI coordinates ( |
| ||
|---|---|---|---|---|---|---|---|
| a) Controls > OMT patients | |||||||
| R | Frontal | Anterior insula, lateral and posterior orbitofrontal cortex, inferior frontal gyrus | 1638 | 44 | 42 | −12 | 5.92 |
| L | Frontal, temporal | Anterior insula, superior temporal pole, inferior frontal gyrus | 234 | −38 | 14 | −14 | 4.27 |
| b) Controls < OMT patients | |||||||
| — | — | — | — | — | — | — | — |
Fig. 1Depiction of (a) smaller GM volume in patients on opioid maintenance treatment, compared to healthy controls [combined voxel-wise (P < 0.001) and cluster-extent (cluster size >103 voxel) threshold, corresponding to pFWE < 0.05 whole brain corrected] in the (b) left and (c) right insula (HC = healthy controls). Illustration of the partial correlations between (d) the subjective feeling of inclusion and (e) the subjective feeling of exclusion during the social ostracism task with GM volume in the left insula in the patient group (r = 0.448, P = 0.047, r = −0.484, P = 0.034, partial correlations considered TIV and age as covariates, residual values are displayed).